Niraparib and dostarlimab for the treatment of recurrent platinum-resistant ovarian cancer: results of a Phase II study (MOONSTONE/GOG-3032)

Leslie M. Randall, David M. O’Malley, Bradley J. Monk, Robert L. Coleman, Stéphanie Gaillard, Sarah F. Adams, Linda Duska, Heather Dalton, Robert W. Holloway, Marilyn Huang, Hye Sook Chon, Noelle Cloven, Adam C. ElNaggar, Roisin E. O’Cearbhaill, Steven Waggoner, Aarti Tarkar, Alina Striha, Linda Nelsen, Amanda Baines, Vivek Samnotra, Panagiotis A. Konstantinopoulos